HMGB1 and myeloid sarcoma: Thus, it is possible that HMGB1 release upon cell death induced by HHV-6A infection and/or reactivation may act as a driver in inflammation in MS, but more studies are needed to further investigate this notion, and to test whether this can happen in vivo.